← All diseases
Cancer
Bile duct cancer
Would you like to receive a message when there is new research on cholangiocarcinoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a one-sentence summary explaining what was studied appears above each publication — and you'll be notified as soon as new research on Cholangiocarcinoma is published. View what Premium costs.
Publications and studies (2068)
- Pyridyl ethyl diazoacetate derivatization enables LC-MS annotation of cholesterol and its metabolites. (2026/10/08) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Biological Selection: The Next Frontier in Liver Transplantation for Perihilar Cholangiocarcinoma? (2026/09/01) ♡
- ASO Author Reflections: Borderline Resectability in Perihilar Cholangiocarcinoma - Anatomic and Biologic Considerations. (2026/08/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Dissemination along the hepatocaval ligament in a caudate-origin intrahepatic cholangiocarcinoma: a case report with video. (2026/08/08) ♡
- Multidisciplinary treatment with conversion surgery after radiological complete response of liver metastasis to gemcitabine, cisplatin, and durvalumab in metastatic distal cholangiocarcinoma. (2026/08/07) ♡
- CircHECTD1 Promotes Cholangiocarcinoma Progression Through Interaction With SFPQ to Induce Autophagy. (2026/08/07) ♡
- The Role of Artificial Intelligence Combined With Digital Cholangioscopy for Indeterminant and Malignant Biliary Strictures: A Systematic Review and Meta-analysis. (2026/08/06) ♡
- ASO Visual Abstract: Anatomic-Biologic Borderline Resectability Criteria Improve Recurrence Risk Stratification in Perihilar Cholangiocarcinoma. (2026/08/06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Implementation and evaluation of an ambulatory care pathway for intra-arterial treatment of primary liver cancer: study protocol for a multicentre randomised controlled hybrid type 1 trial (CHOC). (2026/08/06) ♡
- Transforming routine solid tumor profiling with automated next-generation sequencing: experience from a reference general hospital. (2026/08/05) ♡
- Beyond Anatomy: Tumor Morphology Stratifies Survival After Resection of Cholangiocarcinoma Involving the Hepatic Hilum. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Applications of FDG-PET Imaging in the Management of Patients with Hepatobiliary and Pancreatic Tumors. (2026/08/05) ♡
- Robotic versus laparoscopic liver resection for intrahepatic cholangiocarcinoma in elderly patients: a multicentre propensity-weighted analysis. (2026/08/05) ♡
- Follicular cholangitis: beyond tumour mimicry. (2026/08/04) ♡
- Liver transplantation in primary sclerosing cholangitis with hepatobiliary neoplasia: survival outcomes and impact of diagnostic uncertainty. (2026/08/04) ♡
- Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study. (2026/08/04) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. ASO Editorial: Preoperative Systemic Therapy for Perihilar Cholangiocarcinoma. (2026/08/04) ♡
- HMGA1 is associated with unfavorable outcome and accelerates the aggressiveness of cholangiocarcinoma. (2026/08/04) ♡
- ASO Visual Abstract: Surgical Safety after Preoperative Chemotherapy for Perihilar Cholangiocarcinoma: Multi-institutional Propensity-Matched Analysis. (2026/08/03) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Ultrasound criteria for shallow T2 extrahepatic cholangiocarcinoma-Comment on Okaniwa S. Advanced ultrasound diagnosis of extrahepatic bile duct lesions. J Med Ultrasonics. 2025;52:69-83. (2026/08/03) ♡
- Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703). (2026/08/03) ♡
- Risk of Long-Term Survival After Hepatic Resection for Hepatocellular and Intrahepatic Cholangiocarcinoma: Population-Based Analysis in Korea. (2026/08/03) ♡
- Clinical Outcome and Safety of Procedural Sedation and Analgesia Performed by Interventional Radiologists in Patients Undergoing Local Tumor Ablation of the Liver. (2026/08/02) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: Results from the 2025 French genomic medicine initiative. (2026/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. DNA/RNA-Based Next-Generation Sequencing Improves the Early Diagnosis and Management of Neoplastic Bile Duct Strictures: A 6-Year, Prospective, Multi-Institutional, Real-Time Study. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunoglobulin G4-Related Sclerosing Cholangitis: A Review. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Perihilar Cholangiocarcinoma in Primary Sclerosing Cholangitis. (2026/08/01) ♡
- Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib. (2026/08/01) ♡
- Clinical and Functional Significance of C16orf74 in Extrahepatic Cholangiocarcinoma. (2026/08/01) ♡
- Patterns of progression and efficacy of immune checkpoint inhibitors in unresectable, recurrent, or metastatic cholangiocarcinoma: A real-world study. (2026/08/01) ♡
- An epithelial GPR35 isoform supports tumor-associated transcriptional and metabolic phenotypes. (2026/08/01) ♡
- Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma. (2026/08/01) ♡
- Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic Cholangiocarcinoma. (2026/08/01) ♡
- Comparison of current global guidelines and consensus on the management of patients with cholangiocarcinoma: A 2026 update. (2026/07/31) ♡
- Stereotactic radiosurgery for spinal cholangiocarcinoma metastases: Clinical outcomes and the role of biologically effective dose thresholds. (2026/07/30) ♡
- Diagnosis of feline platynosomosis: case series and literature review. (2026/07/30) ♡
- Three-class radiomic differentiation of hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma on multiphasic contrast-enhanced CT. (2026/07/30) ♡
- Differential Effects of VEGFA and EGF Polymorphisms on Susceptibility and Postoperative Outcome in Cholangiocarcinoma. (2026/07/29) ♡
- Right (H145678) and Left (H123458) 6-Segmentectomies for Malignant Liver Tumors: A Retrospective Analysis of 237 Cases Using Contemporary Surgery Quality Indicators. (2026/07/29) ♡
- EPGD co-delivery of doxorubicin and gemcitabine enhances activity in EpCAM-high tumour models with lower renal injury-associated readouts in a microfluidic co-culture platform. (2026/07/29) ♡
- Histological AI-Assisted Analysis Outperforms Pathologist Assessment in Predicting Disease Outcomes in PSC Patients. (2026/07/29) ♡
- From MyACR to MyμAlbumin: Clinical Validation of a High-Precision, Real-Time Immunoturbidimetric PoC Device for Early Chronic Kidney Disease Detection. (2026/07/28) ♡
- Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort). (2026/07/28) ♡
- Clinical Utility and Safety of a Novel Ultraslim Catheter-Type Peroral Cholangioscope/Pancreatoscope: A Single-Center Case Series. (2026/07/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Grid Radiation Therapy Based on Multileaf Collimator for Neoadjuvant Treatment of Large-Volume Intrahepatic Cholangiocarcinoma: A Case Report. (2026/07/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Upper common bile duct neuroendocrine tumor presenting with obstructive jaundice: a case report and literature review. (2026/07/27) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Minimally Invasive vs. Open Pancreaticoduodenectomy for Distal Cholangiocarcinoma: A Systematic Review and Meta-analysis. (2026/07/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tools and Techniques of Endoscopic Radiofrequency Ablation in Pancreaticobiliary Diseases: A Narrative Review. (2026/07/25) ♡
- ASO Visual Abstract: Investigating Age-Related Differences in Survival Outcomes and Mutation Status in Patients with Intrahepatic Cholangiocarcinoma. (2026/07/25) ♡
- Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma? (2026/07/24) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.